Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease
about
Cortical thickness in relation to clinical symptom onset in preclinical ADPesticide exposure and risk of Alzheimer's disease: a systematic review and meta-analysis.Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.Hippocampal and Amygdala Gray Matter Loss in Elderly Controls with Subtle Cognitive Decline.Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study.Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.Cognitive reserve and cortical thickness in preclinical Alzheimer's disease.Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.The association between tau PET and retrospective cortical thinning in clinically normal elderly.Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology.A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease
P2860
Q37064164-9FC5A7F7-4860-42D6-8FD8-0CA0FE86BCFCQ37223353-40563E64-3A42-45DD-BA81-886E694E0A35Q37627051-69849D5A-13F6-4C33-95B1-42CE75527E62Q37650253-8BDC2526-AC29-4915-9B68-1DBD1CC0220FQ37684370-2AF1A4DB-3434-49EE-856C-9EB046E8CEC0Q39466317-396C4BEA-D78B-455A-B8E2-960A5CA626AAQ40188198-1D835F65-8B55-4889-860F-CDBE74BAD2F1Q42330310-4280966D-B564-4455-BA7D-F72D614096F3Q48560690-3DF407C4-3C6A-45ED-8763-4FEFBC963829Q48818980-357D980B-32D3-450C-9E2B-C52036917AA9Q49322919-5803CF25-E4A9-4852-844B-E0B94BDD486EQ55003313-0CC2093A-C851-4D48-BA2D-29B8CDADF3B7Q57927766-EF42631F-1B12-418D-8826-1F7A88EFFCB3
P2860
Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Spatially distinct atrophy is ...... preclinical Alzheimer disease
@ast
Spatially distinct atrophy is ...... preclinical Alzheimer disease
@en
type
label
Spatially distinct atrophy is ...... preclinical Alzheimer disease
@ast
Spatially distinct atrophy is ...... preclinical Alzheimer disease
@en
prefLabel
Spatially distinct atrophy is ...... preclinical Alzheimer disease
@ast
Spatially distinct atrophy is ...... preclinical Alzheimer disease
@en
P2093
P2860
P1433
P1476
Spatially distinct atrophy is ...... preclinical Alzheimer disease
@en
P2093
Beau M Ances
Christopher Owen
Jason Hassenstab
Jingxia Liu
Liang Wang
Tammie L Benzinger
Tyler Blazey
P2860
P304
P356
10.1212/WNL.0000000000001401
P407
P577
2015-02-25T00:00:00Z